Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lensar Inc (NQ: LNSR ) 5.380 -0.300 (-5.28%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Lensar Inc < Previous 1 2 Next > LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 04, 2024 From LENSAR, Inc. Via Business Wire LENSAR to Participate in Two Upcoming Investor Conferences September 04, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Second Quarter 2024 Results and Provides Business Update August 08, 2024 From LENSAR, Inc. Via Business Wire LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union August 07, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 01, 2024 From LENSAR, Inc. Via Business Wire LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 August 01, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 03, 2024 From LENSAR, Inc. Via Business Wire LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference May 23, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports First Quarter 2024 Results and Provides Business Update May 09, 2024 From LENSAR, Inc. Via Business Wire LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 May 02, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 01, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 01, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update March 04, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 01, 2024 From LENSAR, Inc. Via Business Wire LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 February 26, 2024 From LENSAR, Inc. Via Business Wire LENSAR Reports Third Quarter 2023 Results and Provides Business Update November 09, 2023 From LENSAR, Inc. Via Business Wire LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 November 02, 2023 From LENSAR, Inc. Via Business Wire LENSAR Reports Second Quarter 2023 Results and Provides Business Update August 09, 2023 From LENSAR, Inc. Via Business Wire LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups July 24, 2023 From LENSAR, Inc. Via Business Wire LENSAR Reports First Quarter 2023 Results and Provides Business Update May 15, 2023 From LENSAR, Inc. Via Business Wire LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 May 10, 2023 From LENSAR, Inc. Via Business Wire LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update March 16, 2023 From LENSAR, Inc. Via Business Wire LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 March 09, 2023 From LENSAR, Inc. Via Business Wire LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results February 14, 2023 From LENSAR, Inc. Via Business Wire LENSAR to Present at Two Upcoming Investor Conferences November 22, 2022 From LENSAR, Inc. Via Business Wire LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update November 09, 2022 From LENSAR, Inc. Via Business Wire LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 November 02, 2022 From LENSAR, Inc. Via Business Wire LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU September 08, 2022 From LENSAR, Inc. Via Business Wire First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System August 16, 2022 From LENSAR, Inc. Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
